Drug Trial Radar · NCT02752724
Ketamine Anesthesia for Improvement of Depression in ECT
Last checked: Nov 20, 2026Latest source record: Jun 6, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
52
Actual
Start
Mar 2016
Primary completion
Apr 2017
Study completion Apr 30, 2018
Sponsor
- Lead sponsor
- VA Puget Sound Health Care SystemFederal agency
- Sponsor type
- Federal agency
- First posted
- Apr 27, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this prospective randomized clinical trial is to determine if patients receiving ketamine as a part of general anesthesia during electroconvulsive therapy (ECT) rather than standard of care will have improvement in symptoms of depression after a course of ECT treatments. The investigators hypothesize that utilization of ketamine for induction of general anesthesia during ECT treatments will improve symptoms of depression better than standard care. This study is ONLY open to patients eligible to receive healthcare services through the Department of Veterans Affairs at the VA Puget Sound, which means service in the active military, naval or air service or separation under any condition other than dishonorable. Qualifications for VA health care benefits can be found at va.gov.
Conditions
- Major Depressive Disorder
Interventions
KetamineDrug
Ketamine anesthesia for ECT index course with measurement cerebral metabolic regional oximetry, EEG seizure quality, cognitive scoring and serum metabolites.
MethohexitalDrug
Methohexital anesthesia for ECT index course with measurement cerebral metabolic regional oximetry, EEG seizure quality, cognitive scoring and serum metabolites.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Depression Patient Health Questionnaire 9 (PHQ9) ScoringTime frame: Change from Baseline Score 24 hours prior to starting ECT to PHQ9 score 72 hours following last ECT session
Locations
1 site in 1 country. Site status is shown where the registry gives one.
VA Puget Sound Health Care System
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.